Inside WCLC24 – Recap by Estela Rodriguez Part 2

The WCLC24 is taking place at the San Diego Convention Center from September 7 to 10, 2024.

Organized by the International Association for the Study of Lung Cancer (IASLC), this major conference is gathering leading experts, researchers, and oncologists to present and discuss the latest advancements in lung cancer research, treatment, and personalized therapies, fostering collaborative efforts towards overcoming the challenges of lung cancer.

Estela (Estelamari) Rodriguez, Associate Director of Community Outreach and Co-Lead of Thoracic Site Disease Group of the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, shared a few highlights from the conference:

Puerto Rico in the IASLC map

“When you get to Puerto Rico in the IASLC map and find out it has already been ‘colonized’ by other Boricua Oncologists attending the conference.”

Next Clearing the air

“Next Clearing the Air, Unmasking Indoor Pollutants and Lung Cancer Risk by Roselle de Guzman from Manila.

•  Air pollution is a global health issue.
•  Many workers around the world still exposed to asbestos.”

Impact of Climate Change on lung cancer

“First presentation on the impact of Climate Change on lung cancer outcomes and incidence by Letícia Nogueira, American Cancer Society.
We have 3 choices in climate change:

• Mitigation
• Adaptation
• Solutions”

Rising Influence on Non-Tobacco Risk Factors
“Going on now plenary session on Exploring the Rising Influence on Non-Tobacco Risk Factors , chaired by Linda Martin and patient advocate Dave Bjork.”

Highlight of this trip

“Highlight of this trip was catching up with my former Penn Medicine – Abramson Cancer Center cofellow Marin Xavier Oncologist extraordinairy Scripps Health in San Diego and her family .
The friendships you make along the way in medical training are special.”

Estela (Estelamari) Rodriguez is Associate Director of Community Outreach and Co-Lead of Thoracic Site Disease Group of the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine. She is board certified in medical oncology and hematology. She has a special interest in the early detection of lung cancer and increasing access to clinical trials.

For part 1, click here.